By: Matt Fischer Healthcare marketing arrangements that violate the Anti-Kickback Statute (AKS) can lead ..
By: Matthew Fischer At the end of July, the U.S. Food and Drug Administration (FDA) issued a press release ..
By: Matt Fischer Municipalities throughout the nation continue to use zoning to exclude community residences ..
By: Matt Fischer Florida’s Agency for Health Care Administration (“AHCA”) is the state’s chief ..
By: Matthew Fischer Jumping into the stem cell industry can be an exciting venture. However, with this ..
By: Matthew Fischer In CMS’ latest “MLN Connects” newsletter, the agency discusses the Comprehensive ..
By: Matthew Fischer With the rapid growth of the regenerative medicine field, the U.S. Food and Drug ..
stem cell law By: Matthew Fischer Amid the growing focus on stem cell products by the Federal Food and Drug ..
By: Matt Fischer A recent lawsuit seeking class action status that targeted Zone Program Integrity Contractor ..
By: Matthew Fischer Iowa Senator Chuck Grassley issued a press release last week indicating that he sent ..
By: Matthew Fischer Through two public channels this month, the FDA further solidified its stance on the innovative ..
By: Matthew Fischer The regenerative medicine arena consists of a wide range of innovative products. ..
By: Matthew Fischer Aside from the half million already pending before the Office of Medicare Hearings ..